The Relation Between Serum CEA Response and the CTscan Finding After Neoadjuvant Therapy in Rectal Cancer Patients
The Open Colorectal Cancer Journal · 2012
DOI: 10.2174/1876820201205010001 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Open Colorectal Cancer Journal, 2012. Verfasst von Sami Al-Asari.
Themen: Onkologische Pflege
Abstract (Originalsprache)
The recepteur d'origine nantais (RON) is a member of MET family of receptor tyrosine kinase (RTKs), an overexpression of which has been observed in several cancers.The expression of RON gene is required during embryonic development and also plays critical roles in regulating macrophage inflammatory response.In CRC, the overexpression of moderate RON activity contributes to their oncogenic potential by regulating several key processes such as proliferation, motility and resistance to apoptosis.Interestingly, an aberrant RON expression is often associated with the generation of several splice variants with unique transforming activities.The targeting of RON signaling pathway by the use of monoclonal antibodies and small-molecule inhibitors has shown promising therapeutic results in animal models.The present article aims at summarizing the current understanding of RON kinase in CRC.
Zitieren
APA
Al-Asari, S. (2012). The Relation Between Serum CEA Response and the CTscan Finding After Neoadjuvant Therapy in Rectal Cancer Patients. The Open Colorectal Cancer Journal. https://doi.org/10.2174/1876820201205010001
Vancouver
Al-Asari S. The Relation Between Serum CEA Response and the CTscan Finding After Neoadjuvant Therapy in Rectal Cancer Patients. The Open Colorectal Cancer Journal. 2012. doi:10.2174/1876820201205010001
BibTeX
@article{AlAsari2012,
author = {Al-Asari, Sami},
title = {The Relation Between Serum CEA Response and the CTscan Finding After Neoadjuvant Therapy in Rectal Cancer Patients},
journal = {The Open Colorectal Cancer Journal},
year = {2012},
doi = {10.2174/1876820201205010001}
}
EUVIMED